124 related articles for article (PubMed ID: 28235865)
1. Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses.
Martin P; Palmer G; Rodriguez E; Seemayer CA; Palomo J; Talabot-Ayer D; Gabay C
J Immunol; 2017 Apr; 198(7):2916-2926. PubMed ID: 28235865
[TBL] [Abstract][Full Text] [Related]
2. Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions.
Martin P; Palmer G; Vigne S; Lamacchia C; Rodriguez E; Talabot-Ayer D; Rose-John S; Chalaris A; Gabay C
J Leukoc Biol; 2013 Oct; 94(4):791-802. PubMed ID: 23817563
[TBL] [Abstract][Full Text] [Related]
3. IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages.
Shimizu K; Nakajima A; Sudo K; Liu Y; Mizoroki A; Ikarashi T; Horai R; Kakuta S; Watanabe T; Iwakura Y
J Immunol; 2015 Apr; 194(7):3156-68. PubMed ID: 25725107
[TBL] [Abstract][Full Text] [Related]
4. Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency.
Martin P; Talabot-Ayer D; Seemayer CA; Vigne S; Lamacchia C; Rodriguez E; Finckh A; Smith DE; Gabay C; Palmer G
Arthritis Res Ther; 2013 Jan; 15(1):R13. PubMed ID: 23324173
[TBL] [Abstract][Full Text] [Related]
5. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice.
Lamacchia C; Rodriguez E; Palmer G; Vigne S; Martin P; Talabot-Ayer D; Seemayer CA; Gabay C
Ann Rheum Dis; 2012 Feb; 71(2):281-7. PubMed ID: 22072017
[TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats.
Simeoni E; Dudler J; Fleury S; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G
Eur J Cardiothorac Surg; 2007 Feb; 31(2):222-8. PubMed ID: 17182252
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional characterization of IL-1 receptor type 2 in grass carp: a potent inhibitor of IL-1β signaling in head kidney leukocytes.
Yang X; Wang S; Du L; Yang K; Wang X; Zhang A; Zhou H
Dev Comp Immunol; 2013 Dec; 41(4):738-45. PubMed ID: 23999049
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation.
Rauschmayr T; Groves RW; Kupper TS
Proc Natl Acad Sci U S A; 1997 May; 94(11):5814-9. PubMed ID: 9159157
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis.
Corr M; Boyle DL; Ronacher LM; Lew BR; van Baarsen LG; Tak PP; Firestein GS
Ann Rheum Dis; 2011 May; 70(5):858-63. PubMed ID: 21216819
[TBL] [Abstract][Full Text] [Related]
12. IL-1 receptor 2 (IL-1R2) and its role in immune regulation.
Peters VA; Joesting JJ; Freund GG
Brain Behav Immun; 2013 Aug; 32():1-8. PubMed ID: 23195532
[TBL] [Abstract][Full Text] [Related]
13. ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface.
Uchikawa S; Yoda M; Tohmonda T; Kanaji A; Matsumoto M; Toyama Y; Horiuchi K
Cytokine; 2015 Feb; 71(2):238-45. PubMed ID: 25461404
[TBL] [Abstract][Full Text] [Related]
14. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
[TBL] [Abstract][Full Text] [Related]
15. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
16. Negative regulatory receptors of the IL-1 family.
Garlanda C; Riva F; Bonavita E; Mantovani A
Semin Immunol; 2013 Dec; 25(6):408-15. PubMed ID: 24239046
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 controls acute immune complex-driven arthritis in mice by regulating the inhibitory Fcγ receptor IIB.
Abdollahi-Roodsaz S; Koenders MI; Walgreen B; Bolscher J; Helsen MM; van den Bersselaar LA; van Lent PL; van de Loo FA; van den Berg WB
Arthritis Rheum; 2013 Oct; 65(10):2583-93. PubMed ID: 23860661
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
[TBL] [Abstract][Full Text] [Related]
19. [Cloning and expression analysis of two pro-inflammatory cytokines, IL-1β and its receptor, IL-1R2, in the Asian swamp eel Monopterus albus].
Xu QQ; Xu P; Zhou JW; Pan TS; Tuo R; Ai K; Yang DQ
Mol Biol (Mosk); 2016; 50(5):760-774. PubMed ID: 27830678
[TBL] [Abstract][Full Text] [Related]
20. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
